BioXcel Therapeutics Inc (BTAI)
2.18
-0.06
(-2.90%)
USD |
NASDAQ |
Mar 26, 16:00
2.16
-0.02
(-0.92%)
Pre-Market: 09:16
BioXcel Therapeutics Total Assets (Quarterly): 48.89M for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Omeros Corp | 313.34M |
| Chimerix Inc | 146.01M |
| scPharmaceuticals Inc | 107.52M |
| IGM Biosciences Inc | 265.71M |
| ZyVersa Therapeutics Inc | 19.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 134.52M |
| Shareholders Equity (Quarterly) | -85.63M |
| Debt to Equity Ratio | -1.220 |
| Current Ratio | 1.87 |
| Net Debt Paydown Yield | -5.86% |